These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24793349)

  • 1. Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: a matched cohort study.
    Esteghamati A; Hafezi-Nejad N; Sheikhbahaei S; Heidari B; Zandieh A; Ebadi M; Nakhjavani M
    J Clin Lipidol; 2014; 8(3):279-86. PubMed ID: 24793349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women.
    Zabetian A; Hadaegh F; Azizi F
    Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):525-31. PubMed ID: 18523915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
    Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
    J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
    J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual role of physical workload and occupational noise in the association of the metabolic syndrome with risk of coronary heart disease: findings from the Helsinki Heart Study.
    Koskinen HL; Kauppinen T; Tenkanen L
    Occup Environ Med; 2011 Sep; 68(9):666-73. PubMed ID: 21148595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is metabolic syndrome a useless category in subjects with high cardiovascular risk? Results from a cohort study in men with erectile dysfunction.
    Corona G; Monami M; Rastrelli G; Melani C; Balzi D; Sforza A; Forti G; Mannucci E; Maggi M
    J Sex Med; 2011 Feb; 8(2):504-11. PubMed ID: 21091887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
    Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and incident coronary heart disease in Australian indigenous populations.
    Li M; McCulloch B; McDermott R
    Obesity (Silver Spring); 2012 Jun; 20(6):1308-12. PubMed ID: 21660075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and its components as predictors of all-cause mortality and coronary heart disease in type 2 diabetic patients.
    Protopsaltis I; Nikolopoulos G; Dimou E; Brestas P; Kokkoris S; Korantzopoulos P; Melidonis A
    Atherosclerosis; 2007 Nov; 195(1):189-94. PubMed ID: 17064711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
    Lim HS; Lip GY; Beevers DG; Blann AD
    Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do different metabolic syndrome definitions predict cerebrovascular events and coronary heart disease independent of their components?: 9 years follow-up of the tehran lipid and glucose study.
    Hadaegh F; Mohebi R; Cheraghi L; Tohidi M; Moghaddam NB; Bozorogmanesh M; Sheikholeslami F; Azizi F
    Stroke; 2012 Jun; 43(6):1669-71. PubMed ID: 22382161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and all-cause mortality in older men and women.
    Forti P; Pirazzoli GL; Maltoni B; Bianchi G; Magalotti D; Muscari A; Mariani E; Ravaglia G; Zoli M
    Eur J Clin Invest; 2012 Sep; 42(9):1000-9. PubMed ID: 22591032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome in patients with systemic lupus erythematosus: association with traditional risk factors for coronary heart disease and lupus characteristics.
    Telles R; Lanna C; Ferreira G; Ribeiro A
    Lupus; 2010 Jun; 19(7):803-9. PubMed ID: 20118159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein cholesterol and metabolic syndrome in an Iranian high-risk population.
    Janghorbani M; Amini M
    Diabetes Metab Syndr; 2015; 9(2):91-7. PubMed ID: 25108602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and its individual components with mortality among patients with coronary heart disease.
    Chen Q; Zhang Y; Ding D; Li D; Xia M; Li X; Yang Y; Li Q; Hu G; Ling W
    Int J Cardiol; 2016 Dec; 224():8-14. PubMed ID: 27599384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
    Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
    Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint effect of self-reported sleep problems and three components of the metabolic syndrome on risk of coronary heart disease.
    Loponen M; Hublin C; Kalimo R; Mänttäri M; Tenkanen L
    J Psychosom Res; 2010 Feb; 68(2):149-58. PubMed ID: 20105697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.